# SEG Content Governance Final Handoff

**Mode:** `CONTROLLED GOVERNANCE HANDOFF`  
**Assessment date:** `2026-08-22`  
**Authority:** YaAllah GitLab / SEG governance records remain the primary source of truth. The KISSCRISIS/manus repository remains reference-only.  
**Scope:** Final handoff of the current SEG source-registry, evidence-closure, and bounded recovery state.  
**Final package status:** `SEG_CONTENT_GOVERNANCE_PHASE_COMPLETE`  
**Normalization status:** `NORMALIZATION_BLOCKED`

## 1. Executive Handoff Decision

The SEG governance handoff is complete for the evidence-management phase. The current registry contains seven established source families and one newly intake-reviewed Hamilton candidate. The registry and evidence-closure records show that no source or candidate has completed the evidence and governance gates required for normalization. The permitted state remains controlled internal preservation and evidence inspection only.[1] [2]

This handoff does not approve, normalize, rewrite, map, import, activate, publish, or expose medical content or tools to learners. It records the transition boundary from completed read-only governance preparation to the next authorized evidence-closure activities.[1] [2] [6]

> **Handoff decision:** Preserve all registered sources and candidates, keep them blocked, and proceed only with targeted evidence closure and role-based review preparation. Do not enter normalization or implementation.

## 2. Source Registry Final State

The Master Source Registry contains eight source families/candidates: three P0 sources, four P1 sources, and one Hamilton new candidate. Seven established families remain `BLOCKED_PENDING_EVIDENCE`; Hamilton remains `BLOCKED_PENDING_REVIEW`. All eight are restricted to `INTERNAL_REFERENCE_ONLY` / `WAITING_FOR_EVIDENCE`, and none is ready for normalization.[1]

| Registry item | Current gate | Evidence state | Operational disposition | Normalization readiness | Key handoff note |
|---|---|---|---|---:|---|
| Drug HTML Artifact | `BLOCKED_PENDING_EVIDENCE` | `PARTIALLY_CONFIRMED`; registered HTML SHA-256 is recorded and matched | `INTERNAL_REFERENCE_ONLY` / `WAITING_FOR_EVIDENCE` | No | Canonical source identity, rights, original-source provenance, and exact-artifact Emergency Medicine medication review remain open. |
| OSCE Atlas Package | `BLOCKED_PENDING_EVIDENCE` | `PARTIALLY_CONFIRMED`; recovery container, inner package, text, and 14 PNG evidence are recorded | `INTERNAL_REFERENCE_ONLY` / `WAITING_FOR_EVIDENCE` | No | Original PDF/owner, text and image rights, image-to-source lineage, OSCE clinical review, and visual/accessibility review remain open. |
| PreTest Question Package | `BLOCKED_PENDING_EVIDENCE` | `PARTIALLY_CONFIRMED`; recovered representation matches registered `UPD811-007` hash | `INTERNAL_REFERENCE_ONLY` / `WAITING_FOR_EVIDENCE` | No | Authoritative `pretestnew.pdf`, rights, OCR comparison, provenance, and role-based assessment review remain open. |
| HIPPO High Yield | `BLOCKED_PENDING_EVIDENCE` | `PARTIALLY_CONFIRMED`; text, colored PDF, and DOCX representations are available and checksum-verifiable | `INTERNAL_REFERENCE_ONLY` / `WAITING_FOR_EVIDENCE` | No | Canonical identity/version, representation-specific rights, provenance, professional-track evidence, and exact-representation clinical review remain open. |
| HIPPO QBank | `BLOCKED_PENDING_EVIDENCE` | `PARTIALLY_CONFIRMED`; registered QBank text is checksum-verifiable | `INTERNAL_REFERENCE_ONLY` / `WAITING_FOR_EVIDENCE` | No | Official identity, completeness/numbering, rights, locators, track evidence, and question-level clinical review remain open. |
| FRCEM Representations | `BLOCKED_PENDING_EVIDENCE` | `PARTIALLY_CONFIRMED`; five representations and the byte-identical relationship are recorded | `INTERNAL_REFERENCE_ONLY` / `WAITING_FOR_EVIDENCE` | No | Canonical authority/version, rights, representation-level locators, provenance, track review, and separate study-book/Q&A clinical review remain open. |
| Clinical Images | `BLOCKED_PENDING_EVIDENCE` | `NOT_AVAILABLE` for a standalone artifact or source-specific inventory | Evidence-gap record only; no image use | No | A standalone source package or authoritative locator, per-file hashes, ownership, rights, provenance, image review, and accessibility review are required. OSCE PNGs are not substitutes. |
| Hamilton Ventilator Clinical Engineering Guide | `BLOCKED_PENDING_REVIEW` | `PARTIALLY_CONFIRMED`; ZIP and embedded 19-page PDF are hash-verified | `INTERNAL_REFERENCE_ONLY` / `WAITING_FOR_EVIDENCE` | No | Canonical owner/version/date/locator, original-source and transformation provenance, rights, Emergency Medicine/Critical Care review, biomedical/device review, and track/taxonomy review remain open. |

The Hamilton entry is an intake candidate and does not promote, replace, merge, or alter any prior source. Its archive and PDF hashes verify retained bytes only; they do not establish ownership, license, clinical correctness, device currency, or permission to use the package in SEG.[1] [7]

## 3. Evidence Closure State

The Evidence Closure Decision is complete as a governance decision, not as a declaration that the evidence gates are closed. It records `EXTERNAL_EVIDENCE_REQUIRED` for all eight registry items/candidates, with zero ready for normalization and zero source-replacement reviews triggered.[2]

| Evidence-closure measure | Final state |
|---|---:|
| Established source families requiring further evidence | 7/7 |
| Hamilton candidate requiring further evidence and technical review | 1/1 |
| Sources/candidates ready for normalization | 0/8 |
| Sources/candidates in internal-reference-only / waiting state | 8/8 |
| Final decision `EXTERNAL_EVIDENCE_REQUIRED` | 8/8 |
| Automatic source replacement decisions | 0 |
| Clinical approval or activation decisions | 0 |

The decisive open evidence domains are canonical identity and version, source-specific rights, original-to-extraction-to-recovery-to-registry provenance, source-versioned locators and completeness where applicable, qualified review of the exact retained representation, conflict disposition, professional-track/taxonomy evidence, and append-only governance audit evidence. For Hamilton, separate device-specific technical review is additionally required.[2]

A separate JEM Nexus calculator evidence-closure report exists and remains `EXTERNAL_EVIDENCE_REQUIRED` / `BLOCKED_PENDING_EVIDENCE`. It is not part of the eight-item Master Source Registry count because no authorized Master Registry update for JEM Nexus has been performed. It must not be silently treated as a registered or normalized source.[5]

## 4. Recovery Completion

The bounded read-only Full Recovery batch is complete under `SEG_FULL_RECOVERY_BATCH_COMPLETE`. The batch established or reconfirmed artifact availability, integrity evidence, registered SHA-256 matches, representation inventories, and negative recovery where a standalone artifact was not found. OSCE recovery was completed as a separate controlled recovery activity. Recovery completion is an execution-completeness status and is not equivalent to rights closure, medical approval, technical approval, normalization readiness, or activation.[3] [4]

Clinical Images remains a negative recovery result for the standalone source family: no source-specific artifact, archive, registered image inventory, per-file manifest, or authoritative locator is available in the reviewed evidence paths. The 14 OSCE PNGs remain a separate OSCE family and cannot satisfy the Clinical Images requirement.[1] [2] [4]

## 5. Remaining Risks and Blockers

The principal risk is governance overreach: treating a verified local file, checksum, structural inventory, application bundle, or recovery completion status as proof of canonical identity, ownership, license, clinical validity, completeness, or permission to publish. That interpretation is expressly excluded by the current registry and evidence-closure decisions.[1] [2]

| Risk/blocker | Affected scope | Required control |
|---|---|---|
| Canonical identity, publisher/owner, version, date, and original locator are incomplete | All seven established families and Hamilton; JEM separately | Obtain attributable external or authoritative evidence before reconsideration. |
| Rights and redistribution evidence is incomplete | All registered families; Hamilton additionally includes translation, code, and visual rights | Preserve internally only; do not display, redistribute, publish, or expose to learners. |
| Exact-representation clinical review and conflict disposition are absent | All registered families; Hamilton additionally requires ventilator/device review | Assign review through the authorized governance process; do not infer approval from intake. |
| Provenance chain is incomplete | All registered families and Hamilton | Close original source, extraction event, recovery artifact, and registry relationship with source-versioned locators. |
| Standalone Clinical Images artifact is missing | Clinical Images | Recover or independently locate a source-specific package; do not substitute OSCE PNGs. |
| Hamilton device currency and configuration are unverified | Hamilton | Review against the current HAMILTON-G5/HAMILTON-S1 operator manual, exact configuration, and software version by a device-qualified reviewer. |
| JEM Nexus is outside the current Master Registry | JEM Nexus candidate | Keep its closure report separate and require an explicit future registry decision before any registry-level treatment. |

## 6. Next Authorized Phase

The next authorized phase is **targeted evidence closure and governance preparation**, source by source. The permitted sequence remains:

```text
External / authoritative evidence acquisition
        ↓
Identity, rights, provenance, track, and locator verification
        ↓
Exact-representation clinical and specialist review
        ↓
Conflict and audit decision record
        ↓
Evidence Closure Decision reconsideration
        ↓
First Source Ready For Normalization
        ↓
SEG_CONTENT_RECORD_V1_1
```

The first source may enter normalization only after its evidence is complete, independently attributable, internally consistent, and separately authorized through the existing SEG governance process. No source, Hamilton, or JEM Nexus may bypass this sequence.[1] [2] [3]

## 7. Final Validation and Non-actions

The Phase 6 handoff was documentation-only. No SQL file, Prisma model, Zod contract, database object, migration, import, seed, mapping, activation, publication, learner exposure, source deletion, source replacement, source merge, application change, Supabase change, or Git operation was authorized or performed as part of this handoff.

The conditional Phase 5 item `SEG_CONTENT_NORMALIZATION_PLAN.md` was not created because the normalization gate is explicitly not approved. The next permitted action is evidence closure, not normalization planning or implementation.[6]

> **Final status:** `SEG_CONTENT_GOVERNANCE_PHASE_COMPLETE`
>
> **Operational boundary:** `NORMALIZATION_BLOCKED`
>
> **Next allowed phase:** Targeted evidence closure and role-based governance review.

## References

[1]: /home/ubuntu/seg-internship-output/SEG_MASTER_SOURCE_REGISTRY_STATUS.md "SEG Master Source Registry Status"
[2]: /home/ubuntu/seg-internship-output/SEG_EVIDENCE_CLOSURE_DECISION_REPORT.md "SEG Evidence Closure Decision Report"
[3]: /home/ubuntu/seg-internship-output/SEG_FULL_CONTENT_RECOVERY_EXECUTION_PLAN.md "SEG Full Content Recovery Execution Plan"
[4]: /home/ubuntu/seg-internship-output/SEG_MASTER_RECOVERY_STATUS_UPDATE.md "SEG Master Recovery Status Update"
[5]: /home/ubuntu/seg-internship-output/SEG_JEM_NEXUS_EVIDENCE_CLOSURE_REPORT.md "SEG JEM Nexus Evidence Closure Report"
[6]: /home/ubuntu/upload/SEG_FINAL_REMAINING_GOVERNANCE_COMMANDS.md "SEG Final Remaining Governance Command Package"
[7]: /home/ubuntu/seg-internship-output/SEG_HAMILTON_VENTILATOR_SOURCE_INTAKE_REVIEW.md "SEG Hamilton Ventilator Guide Source Intake Review"

---

**Document control:** Prepared by **Manus AI**. This handoff records governance state and allowed future actions only. It does not approve, normalize, map, import, activate, publish, replace, merge, delete, or modify any medical source or production system.
